Rare Diseases: The Hidden Epidemic | Vibepedia

Rare diseases, also known as orphan diseases, affect approximately 3.5% of the global population, with over 7,000 distinct conditions identified to date. Despite their individual rarity, these diseases collectively impact millions of people worldwide, with many going undiagnosed or misdiagnosed. The lack of awareness, research, and treatment options for rare diseases has led to a significant gap in healthcare, leaving patients and families to navigate a complex and often frustrating system. According to the National Institutes of Health (NIH), only about 5% of rare diseases have an FDA-approved treatment, highlighting the need for increased funding and innovation in this area. The rare disease community has been instrumental in driving change, with organizations like the Rare Diseases Act of 2002 and the Global Genes Project working to raise awareness and advocate for patient rights. As research and technology continue to advance, there is hope for improved diagnosis, treatment, and care for those affected by rare diseases, with a growing number of companies, such as Biogen and Pfizer, investing in rare disease research and development.